An Ebola vaccine based on the same technology that delivered the AstraZeneca Covid-19 jab is being urgently developed by British scientists to help contain the deadly sub-strain enveloping the Democratic Republic of Congo (DRC) and its neighbors.
The Daily Telegraph reports the new vaccine is being developed by the Oxford Vaccine Group (OVG) using the platform deployed in 2020 as a baseline start.
The vaccine technology, called ChAdOx1, uses a harmless genetically engineered version of the common cold virus which normally infects chimpanzees.
The World Health Organisation (W.H.O.) declared the outbreak a public health emergency of international…
Read the full article at BREITBART.COM
